Literature DB >> 35359530

Clinico-Pathological Features in Köhlmeier-Degos Disease with Cutaneous and Neurological Involvement.

Dodmallur Mallikarjuna Sindhu1, Sumanth Shivaram1, Shilpa Rao2, Madhu Nagappa1, Doniparthi V Seshagiri1, Vani Santosh2, J Madhukara3, A S Shreedhara4, Maya D Bhat5, Rose D Bharath5, Sanjib Sinha1.   

Abstract

Entities:  

Year:  2021        PMID: 35359530      PMCID: PMC8965922          DOI: 10.4103/aian.AIAN_1004_20

Source DB:  PubMed          Journal:  Ann Indian Acad Neurol        ISSN: 0972-2327            Impact factor:   1.383


× No keyword cloud information.
Sir, Köhlmeier–Degos disease or Degos disease or malignant atrophic papulosis is a rare chronic obliterative vasculopathy of uncertain etiology. It affects skin and other organs such as the gastrointestinal tract and the central nervous system, in addition to the heart, lungs, kidneys, and eyes.[1] It can be classified as (i) malignant Degos disease with systemic manifestations which is further subclassified as (a) autoimmune: when there are associated clinical and/or laboratory features of either connective tissue disease or vasculitis, (b) coagulopathy-associated, and (c) virally induced, and (ii) benign cutaneous type which lacks systemic manifestations even after years of onset.[1] The disease usually manifests in adults, has male preponderance, and has been more commonly reported from the Caucasian population.[1] We describe the clinical course in a patient with Degos disease having neurological involvement and highlight the imaging and histological findings. A 44-year-old gentleman developed one episode of focal-to-bilateral tonic–clonic seizure. Examination four hours after the seizure was normal. He had diffuse skin lesions for about 2 years [Figure 1a and b]. He did not have preexisting scarring acne on the face. Brain MRI showed enhancing multifocal T2/FLAIR hyperintense lesions [Figure 1c–g]. Stereotactic biopsy of the right temporal lesion showed areas of coagulative necrosis/infarct which was indicative of vasculopathy/vasculitic process [Figure 2a–d]. Brain MRI after 2 months showed an increase in the size of the lesions [Figure 1h, i, and j]. The histopathological findings of skin biopsy are depicted in Figure 3a–d. He was treated empirically with intravenous methyl prednisolone (1 g/day for 5 days). One month later, he developed sudden onset, non-progressive, impaired vision in the right eye. Examination revealed bilateral optic disc edema, soft retinal exudates, and right inferior temporal quadrantanopia. Brain MRI done 4 days after the onset of new deficits showed no new lesions. There was evidence of “blooming” in susceptibility-weighted images within these lesions [Figure 1k and l]. Hematological and biochemical investigations were significant for an elevated erythrocyte sedimentation rate (52 mm/first hour). Work up for immune-mediated and granulomatous disorders and serological testing for human immunodeficiency virus, hepatitis B, and hepatitis C viruses were negative. Cerebrospinal fluid analysis showed normal opening pressure and slightly elevated protein (50.9 mg/dL, ref.: 15–45 mg/dL). CT scan of chest and abdomen was normal. Based on the clinical and histological findings of the characteristic skin lesions, the patient was diagnosed to have Degos disease. He was treated with monthly pulsed intravenous methylprednisolone along with levetiracetam, clopidogrel, and cilostazole. His visual deficits remained status quo. There was no recurrence of seizures. Skin lesions increased in number. He developed gastrointestinal symptoms in the form of vomiting and diarrhea alternating with constipation and he succumbed to his illness around one year after onset of neurological symptoms.
Figure 1

(a, b) Clinical photographs showing papular skin lesions with a porcelain-white center and erythematous margin over the posterior aspect of trunk and limbs. (c–e) Axial sections of brain MRI show hyperintense lesions in the right frontal and posterior temporal and left parietal in T2 sequences. (f and g) Postcontrast T1W sequences show enhancement of the periphery of lesions. (h,i, and j) Brain MRIs after 2 months of onset show increase in the size of the lesions. (k and l) Blooming seen on SWI within the lesions. (m–q) Brain MRI after the onset of visual symptoms shows persistence of the lesions

Figure 2

(a) Biopsy of the right posterior temporal brain lesion shows thickened leptomeningeal vessel with perivascular inflammation (H&E, 100×). (b and c) Cortical vessels with fibrin thrombus (arrow) and vessel wall inflammation (H&E, 200×). (d) Thrombosed vessel with parenchymal infarct (H&E, 200×)

Figure 3

(a) Biopsy of skin shows thinned out epidermis (H&E, 100×). (b) Basal layer shows vacuolation (H&E, 200×). (c) Inflammatory infiltrate with karryorhectic debris is noted (H&E, 200×). (d) A dermal vessel shows sclerosis and damage to the wall (H&E, 200×)

(a, b) Clinical photographs showing papular skin lesions with a porcelain-white center and erythematous margin over the posterior aspect of trunk and limbs. (c–e) Axial sections of brain MRI show hyperintense lesions in the right frontal and posterior temporal and left parietal in T2 sequences. (f and g) Postcontrast T1W sequences show enhancement of the periphery of lesions. (h,i, and j) Brain MRIs after 2 months of onset show increase in the size of the lesions. (k and l) Blooming seen on SWI within the lesions. (m–q) Brain MRI after the onset of visual symptoms shows persistence of the lesions (a) Biopsy of the right posterior temporal brain lesion shows thickened leptomeningeal vessel with perivascular inflammation (H&E, 100×). (b and c) Cortical vessels with fibrin thrombus (arrow) and vessel wall inflammation (H&E, 200×). (d) Thrombosed vessel with parenchymal infarct (H&E, 200×) (a) Biopsy of skin shows thinned out epidermis (H&E, 100×). (b) Basal layer shows vacuolation (H&E, 200×). (c) Inflammatory infiltrate with karryorhectic debris is noted (H&E, 200×). (d) A dermal vessel shows sclerosis and damage to the wall (H&E, 200×) Neurological involvement is reported in 20–60% of patients with Degos disease.[2] In a case series from the Mayo Clinic, 10 out of 15 patients had neurological manifestations, including fatal hemorrhagic or ischemic strokes, polyradiculoneuropathy, and nonspecific symptoms. More than half the patients had only cutaneous manifestations.[3] As noted in our patient, the skin lesions antedate neurological manifestations by weeks to years. Uncommonly, neurological features can precede or occur simultaneously with skin lesions.[4] Any part of the neuraxis can be affected and the clinical manifestations correspond to the site of involvement. Our patient manifested with neurological and ophthalmological features in the form of seizures, quadrantanopia, and multifocal brain lesions, which were secondary to vasculopathy of the leptomeningeal and cortical vessels. He also developed optic disc edema in the absence of raised intracranial pressure raising the possibility of optic nerve head ischemia secondary to retinal artery involvement. Table 1 summarizes the neurologic manifestations reported in literature.[23456789]
Table 1

Neurologic manifestations of Degos disease reported in literature

SitePresentation
BrainVenous thrombosis, hemorrhage, infarct involving supra- or infratentorial regions leading to headache, seizures, cognitive decline, dysarthria, aphasia, hemiparesis, amaurosis fugax, brainstem dysfunction
Tear drop calcifications in cerebral parenchyma
Progressive unilateral occlusion of cerebral vessels leading to hemispheric atrophy and thinning of overlying calvarium
Spinal cordMyelopathy with patchy peripheral lesions (“saw-tooth” or “moth-eaten” appearance) and thinning of cord
Peripheral nervous systemOptic neuropathy
Radiculopathy
Sensori-motor polyneuropathy
Myopathy
Extra-axialEnhancing leptomeningeal nodules
Diffuse meningeal enhancement
Ependymal enhancement
Subdural effusion (due to blockage of CSF flow) can mimic battered baby syndrome in infants
Neurologic manifestations of Degos disease reported in literature The clinical course is progressive, sometimes fulminant, with the appearance of new neurological deficits as was noted in our patient. Fatal outcome has been reported in majority of the patients.[57] Death occurs from bowel perforation, large cerebral infarcts, or massive cerebral hemorrhage. Rarely patients have mild or transient deficits.[10] The key determinant of mortality is the degree of vascular involvement and ischemic complications. The factors that determine whether the disorder remains benign and confined to the skin or becomes malignant with other organ system involvement are not known. Establishing an early and accurate diagnosis is important to ensure close follow-up for extracutaneous organ involvement. Diagnosis rests on identifying the characteristic skin lesions as noted in our patient, which is further supported by histological studies. Other neurological disorders where cutaneous lesions aid in the etiological diagnosis are listed in Table 2. Treatment of Degos disease includes immunosuppressive agents, antiplatelets, anticoagulants, rheological agents, and prostaglandins like treprostinil.[1] There is no effective treatment for Degos disease since the understanding of the underlying pathophysiology is incomplete. Increased platelet aggregation and fibrinolytic dysfunction have been noted.[1] Familial occurrence with autosomal dominant inheritance has been reported. Autoimmunity appears to play a major role as evidenced by presence of autoantibodies like antiphospholipid antibodies. Besides, as noted in our patient, histopathological findings of the skin and brain suggest vasculopathy. Other studies including autopsy-based studies provide evidence for obstructive vasculopathy of small and medium-sized vessels, with variable degree of inflammation, sparing the tunica media.[2] Histological changes in the skin evolve in early, fully developed, and late lesions.[1] Based on the available evidence, various mechanisms have been proposed to explain the clinical manifestations of this disease including vasculitis, coagulopathy, and endothelial dysfunction triggered by viral or bacterial infections.[1] How the interplay of genetics, autoimmunity and coagulopathy drives the disease process and contributes to the obstructive vasculopathy of Degos disease still remains to be understood.
Table 2

Differential diagnosis of central nervous system disorders with pathognomonic skin lesions

Disease/SyndromeNeurological featuresCutaneous featuresHistological findings
Inflammatory disorders
 APLAIschemic strokes, Sneddon’s syndrome, transverse myelitis, choreaLivedo reticularis, acrocyanosis, Degos-like lesions, erythematous macules, purpura, ecchymoses, and subungual splinter hemorrhagesOcclusive vascular changes, thrombotic microangiopathy, arterial intimal fibrous hyperplasia
 SLEEncephalopathy, chorea, strokes, psychosis, optic neuropathy, peripheral neuropathy, myopathy, myasthenia gravisPhotosensitivity, malar rash, discoid lupus, alopecia, mucosal ulcers, Raynaud phenomenon, angioneurotic edema, palpable purpura, subcutaneous nodules, gangrene, erythema multiformeVasculopathy, micro-/macro-infarction, focal/diffuse vasculopathy
 SarcoidCranial neuropathies, chronic meningitis, peripheral neuropathy, myopathy, hypothalamic involvementDry skin, hypohidrosis, cicatricial alopecia, erythema nodosum, vesicles, maculopapular rash, lupus pernio, plaques, keloidsNoncaseating granuloma
 Behcet’s diseaseAseptic meningitis, encephalitis, myelitis, CVT, isolated trigeminal neuralgiaErythema nodosum, genital ulcers, oral aphthous ulcers, dermatographia, vesicles, pustules, folliculitis, pyoderma, acneiform eruptions, and necrotising vasculitisIntense inflammatory infiltration by polymorphs, eosinophils, lymphocytes, and macrophages, necrosis, and apoptotic neuronal loss. Intense inflammatory infiltration of small vessels can occur, fibrinoid necrosis is not seen
 Sjögren’s syndromeAseptic meningitis, CVT, peripheral neuropathy, dorsal ganglionopathyRaynaud’s phenomenon, purpura, xerostomiaNecrotic lesions, perivascular cuffing
 Rheumatoid arthritisPachymeningitis, leptomeningitis, CNS vasculitis, myelopathy, mononeuritis multiplexSubcutaneous nodules, liver palms, vivid washable yellow discolorationRheumatoid nodules, pachymeningitis, leptomeningitis, vasculitis
Genetic disorders
 Tuberous sclerosisSubependymal giant-cell astrocytomas, behavioral problems, autism, West syndromeAsh leaf spots, confetti-like hypopigmented patches, café-au-lait spots, shagreen patches, periungual fibromas, facial angiofibromasCortical tubers, neuroglial hamartomas Vascular calcification
 Neurofibromatosis 1 and 2Optic nerve gliomas, radiculopathy, acoustic neuromas, schwannomaCafé-au-lait spots, fibromatous dermal tumors, and Lisch nodules, axillary or inguinal region freckling, neurofibromas, violaceous papillary skin neurofibromasMicronodular capillary and arteriolar proliferations. Glial proliferations are hamartomatous in nature
 Hereditary hemorrhagic telangiectasia (HHT)/Osler–Weber–Rendu syndromeIschemic strokes, subarachnoid hemorrhagesMucocutaneous telangiectasiasVascular dysplasia
 HomocystinuriaIschemic strokes, mental retardation, seizures, personality disorders, depressionCutaneous hypopigmentation, malar flush, and livedo reticularis
 PorphyriasEncephalopathy, psychosis, neuropathic abdominal pain, peripheral neuropathyBlisters, postinflammatory hyperpigmentation
 Sturge–WeberLeptomeningeal venous malformation, epilepsy, developmental delayCongenital port wine stain over the faceTortuous, thin-walled leptomeningeal blood vessels, dystrophic mineralization in cortex and white matter, cortical atrophy, subpial gliosis, focal cortical dysplasia type Ia
Ataxia Telangiectasia/Louis-Bar syndromeAtaxia, choreoathetosis, seizures, oculomotor abnormalitiesCutaneous telangiectasia, café-au-lait spots, progeric and sclerodermatous changesLoss of myelinated fibers in the posterior funicles, cortical atrophy, loss of the internal granular layer, Purkinje cell loss, empty baskets, hypertrophy of the Bergman glia, degeneration of dentate nucleus
 Fabry diseasePainful small fiber neuropathy with autonomic involvement, seizuresPurpuric, skin rash, angiokeratoma diffusumHydropic deep white matter, neuronal ballooning due to glycolipid storage Angiopathy of subarachnoid arteries due to medial thickening from glycolipid deposition in smooth muscles and adventitial fibrosis with lymphocytic infiltration
 Pseudoxanthoma elasticumStroke, retinopathyPseudoxanthoma, multiple papules, peau d’ orange, angioid streaks, subcutaneous calcification usually in blood vesselsSkin shows calcium deposits and swollen, fragmented elastic fibers
Infections
 SyphilisAseptic meningitis, late meningovascular syphilis, tabes dorsalisPrimary: Chancre. Secondary: maculopapular nonpruritic scaling rash, patchy alopecia, condyloma lata, mucous patches, erythema multiforme, split papulesExtensive leukocyte infiltration into the meninges, with perivascular leukocyte infiltration. Fischer’s plaques
 TuberculosisChronic meningitis, vasculitic infarcts, Pott spine, CNS tuberculomasPrimary tuberculous chancre, verrucosa cutis, lupus vulgaris, scrofuloderma, erythema nodosum, erythema multiformeLymphohistiocytic meningitis with or without caseous necrosis. Tubercular granuloma with multinucleate giant cells
 Varicella zosterMeningitis with cerebellar ataxiaVesicles with oral lesionsMultifocal vasculopathy, lymphocytes, and macrophages infiltrating the arterial media
 CryptococcosisChronic meningitisMacules and nodules (in 10-15% of cases)Meninges diffusely infiltrated with numerous cryptococci and mononuclear cells, occasional granulomatous reaction, and necrosis
 Lymes diseaseAseptic meningitis, polyneuropathy, delayed demyelinating diseaseTarget lesionVisible ependymal granulation, irregular nodular protrusions of subependymal glia. Leptomeninges show mild fibrosis and chronic infiltrate of lymphocytes
 HIVHIV-1-associated neurocognitive disorder (HAND), peripheral neuropathy, progressive multifocal encephalopathy, tuberculosis, toxoplasmosis, and infection with cytomegalovirusMolluscum contagiosum, seborrheic dermatitis, verruca vulgaris, Kaposi sarcoma, herpes zosterMultinucleated giant cells, microglial nodules/myelin loss
Neoplastic
 LeukemiaMeningeal leukemia is common form of relapse, seen in ALLErythema nodosum, Sweet syndrome
 Lymphoma, cutaneous (T cell)Subacute meningitis, vertebral metastasesScaly erythematous patches, leonine facies, poikiloderma, hypopigmented and hyperpigmented patches with atrophy and telangiectasia
Differential diagnosis of central nervous system disorders with pathognomonic skin lesions We highlight the clinical, radiological, and histological findings in a patient with systemic Degos disease and stress on meticulous skin examination as a crucial step in the diagnostic algorithm. It is important to establish an accurate diagnosis for counseling the patient regarding the prognosis. Knowledge gaps in the disease pathophysiology need to be filled so as to develop effective targeted therapies.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  10 in total

1.  Case records of the Massachusetts General Hospital. Case 38-2006. A 5-year-old boy with headache and abdominal pain.

Authors:  Verne S Caviness; Pallavi Sagar; Esther J Israel; Bonnie T Mackool; Eric F Grabowski; Matthew P Frosch
Journal:  N Engl J Med       Date:  2006-12-14       Impact factor: 91.245

2.  A case of Degos disease in pregnancy.

Authors:  Sapna Sharma; Barbara Brennan; Ray Naden; Patrick Whelan
Journal:  Obstet Med       Date:  2016-06-01

3.  The evolution of cerebrovascular changes in Köhlmeier-Degos disease: An 11-year follow-up case report.

Authors:  Louie Ye; Ernest Lekgabe; Alpha Tsui; Frank Gaillard
Journal:  J Clin Neurosci       Date:  2017-11-26       Impact factor: 1.961

4.  Nervous system involvement in Degos disease.

Authors:  Carmelo Amato; Raffaele Ferri; Maurizio Elia; Filomena Cosentino; Carmelo Schepis; Maddalena Siragusa; Massimo Moschini
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

5.  Infantile neurological Degos disease.

Authors:  Tong Hong Yeo; Grace Vassallo; Mary Judge; Nigel Laycock; Anna Kelsey; Yanick J Crow
Journal:  Eur J Paediatr Neurol       Date:  2010-07-24       Impact factor: 3.140

6.  Optic nerve and spinal cord manifestations of malignant atrophic papulosis (Degos disease).

Authors:  F Matsuura; K Makino; T Fukushima; N Matsubara; M Shibuya; T Higuchi; H Hashidate; M Yamada; H Shibuya; M Yamazaki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

7.  CNS involvement in malignant atrophic papulosis (Kohlmeier-Degos disease): vasculopathy and coagulopathy.

Authors:  D K Dastur; B S Singhal; H J Shroff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-02       Impact factor: 10.154

8.  Degos disease: a new simulator of non-accidental injury.

Authors:  Celia Moss; Evangeline Wassmer; Geoff Debelle; Scott Hackett; Helen Goodyear; Roger Malcomson; Clive Ryder; Spyros Sgouros; Hossain Shahidullah
Journal:  Dev Med Child Neurol       Date:  2009-06-22       Impact factor: 5.449

9.  Skin lesion with a fatal neurologic outcome (Degos' disease)

Authors:  P Subbiah; E Wijdicks; M Muenter; J Carter; S Connolly
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

Review 10.  Malignant atrophic papulosis (Köhlmeier-Degos disease) - a review.

Authors:  Athanasios Theodoridis; Evgenia Makrantonaki; Christos C Zouboulis
Journal:  Orphanet J Rare Dis       Date:  2013-01-14       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.